New guide explains how to achieve a healthy measurement system
Topics covered include why, how and when instruments should be calibrated to ensure they are delivering accurate measurement.
ABB has released a new guide explaining how to keep your instruments and analysers in top working condition. Titled ‘How to check whether your installed instrumentation is in need of a health check’, the guide covers the key factors to consider when assessing the operational performance of measurement equipment.
Topics covered include why, how and when instruments should be calibrated to ensure they are delivering accurate measurement. Many users mistakenly assume that the calibrated accuracy of an instrument will endure throughout its operational life, potentially resulting in incorrect measurements that could have a major impact on production and profitability. The section explains how to create an effective calibration regime and how to spot when an instrument may be in need of recalibration.
The guide also provides advice on the new possibilities being unlocked by advances in instrument technology, particularly when it comes to the availability of diagnostic data. The latest generation of smart digital instruments, coupled with developments in communication technology such as WirelessHART, have helped to unlock new possibilities for gaining quick and easy access to an expanded range of instrument data. Foremost amongst these is the ability to obtain a clearer picture of what is happening in a process. The ability to convey a greater range of data from a device at faster speeds over a digital network enables real or near real-time data to be obtained on process conditions, which can then be used to identify areas for possible improvement.
Other topics covered include guidance on inspecting instruments to check for deteriorating performance and tips for designing and implementing safety instrumented systems in critical safety applications.
“The scale and complexity of many industrial sites means that many companies may be unsure about the age, condition or even location of some of their installed instruments,” says Wayne Deeks for ABB UK Measurement & Analytics Service. “Our new guide aims to provide an easy to use point of reference for anyone looking to improve the performance of their process through more effective measurement.”
To obtain a copy of the guide, email [email protected] quoting reference ‘Health check guide’.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance